Stock XFOR X4 PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications X4 Pharmaceuticals, Inc.

Equities

XFOR

US98420X1037

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-06 pm EDT 		5-day change 1st Jan Change
1.2 USD +4.35% Intraday chart for X4 Pharmaceuticals, Inc. +10.09% +43.11%
Apr. 30 HC Wainwright Adjusts Price Target on X4 Pharmaceuticals to $5 From $3, Maintains Buy Rating MT
Apr. 29 Pantherx® Rare Partner with X4 Pharmaceuticals Inc. for the Distribution of Xolremdi? (Mavorixafor), the First FDApproved Therapy Indicated for Use in Patients with Whim Syndrome CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. XFOR Stock
  4. News X4 Pharmaceuticals, Inc.
  5. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW